wow wee, maybe the market isn't for you.
how did you expect a biopharma spec play to get money for the RnD of their anti-bacterial products, phase 2 trials of psorarsis and potentially phase 3 developments .... think.
it's not deceitful. you were aware, you just expected it later.
let's not jump the gun. email management, you'll find out who the US biotech fund is. it's great.
yeah, Bell P and Argo involvement doesn't slide with me. but I am confused to how it works if they're getting 40M from the US ...... are they just stitching it together? do they have a smaller portion? no idea.
wow wee, maybe the market isn't for you. how did you expect a...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |